Atherosclerotic disease

There are 17 papers on atherosclerotic disease in aging research: 10 observational studies in people, 1 in animals, 6 reviews. The newest story, Nov 9, 2026: “Evolocumab linked to fewer deaths in high-risk adults”.

Disease

17 papers study it178 more mention it3 findings

29 new papers in 30 daysSee all 195 papers on atherosclerotic disease

“SCAD polygenic risk demonstrated inverse associations with atherosclerotic phenotypes and positive associations with aneurysm phenotypes”
Phenome-Wide Analysis of SCAD Polygenic Risk Defines Vascular Pleiotropy and Sex-Specific AssociationsAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.15627
  • Humans10
  • Animals1

Associations

3

SCAD polygenic risk score

downin humans1

1 study
  1. SCAD polygenic risk score is associated with atherosclerotic disease in humans.

    Humans

More on SCAD polygenic risk score

Clonal hematopoiesis of indeterminate potential

upin humans1

1 study
  1. Clonal hematopoiesis of indeterminate potential raises the risk of atherosclerotic disease in humans.

    Review

More on Clonal hematopoiesis of indeterminate potential

Telomere length

downin humans1

1 study
  1. Atherosclerotic disease is associated with telomere length in humans (Patients with atherosclerotic diseases and cardiovascular risk factors).

    ReviewPatients with atherosclerotic diseases and cardiovascular risk factorsleukocyte

More on Telomere length

Trial sponsors

Funding

2 grants since 2025

Japan Society for the Promotion of Science¥23.4M

Latest

Dec 2025: 1Jan 2026: 9Feb 2026: 4Mar 2026: 11Apr 2026: 1May 2026: 3Jun 2026: 2Jul 2026: 5Aug 2026: 9Sep 2026: 10Oct 2026: 17Nov 2026: 1587 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Evolocumab linked to fewer deaths in high-risk adults

Over three years, deaths occurred in 1.4% of evolocumab users versus 2.7% of alirocumab users across 2,610 matched pairs.Over three years, deaths occurred in 1.4% of evolocumab users versus 2.7% of alirocumab users across 2,610 matched pairs.

Cohort studyEvolocumab
ESC Congress 2026 Abstract

Heart defects linked to more complications in artery disease

An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.

Cohort · 35,064 peoplePopulations

See all 195 papers on atherosclerotic disease